A Study to Evaluate the Effects of E2609 on QTc Interval in Healthy Subjects
Clinical trial NCT02222324 · COMPLETED
Trial details
- NCT number
- NCT02222324
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-01
- Primary completion
- 2014-10-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.